Does OFATUMUMAB Cause Dysstasia? 158 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 158 reports of Dysstasia have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.5% of all adverse event reports for OFATUMUMAB.
158
Reports of Dysstasia with OFATUMUMAB
0.5%
of all OFATUMUMAB reports
2
Deaths
35
Hospitalizations
How Dangerous Is Dysstasia From OFATUMUMAB?
Of the 158 reports, 2 (1.3%) resulted in death, 35 (22.2%) required hospitalization, and 4 (2.5%) were considered life-threatening.
Is Dysstasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 158 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Dysstasia?
ADALIMUMAB (1,181)
DALFAMPRIDINE (1,128)
METHOTREXATE (739)
SECUKINUMAB (637)
ETANERCEPT (602)
PREGABALIN (544)
CARBIDOPA\LEVODOPA (457)
PIMAVANSERIN (406)
TOFACITINIB (380)
DIMETHYL (352)
Which OFATUMUMAB Alternatives Have Lower Dysstasia Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB